For: | Siebler J, Galle PR. Treatment of nonalcoholic fatty liver disease. World J Gastroenterol 2006; 12(14): 2161-2167 [PMID: 16610015 DOI: 10.3748/wjg.v12.i14.2161] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i14/2161.htm |
Number | Citing Articles |
1 |
Silvio Ken Garattini, Debora Basile, Monica Cattaneo, Valentina Fanotto, Elena Ongaro, Marta Bonotto, Francesca V Negri, Rosa Berenato, Paola Ermacora, Giovanni Gerardo Cardellino, Mariella Giovannoni, Nicoletta Pella, Mario Scartozzi, Lorenzo Antonuzzo, Nicola Silvestris, Gianpiero Fasola, Giuseppe Aprile. Molecular classifications of gastric cancers: Novel insights and possible future applications. World Journal of Gastrointestinal Oncology 2017; 9(5): 194-208 doi: 10.4251/wjgo.v9.i5.194
|
2 |
M Barber, A Murrell, Y Ito, A‐T Maia, S Hyland, C Oliveira, V Save, F Carneiro, AL Paterson, N Grehan, S Dwerryhouse, P Lao‐Sirieix, C Caldas, RC Fitzgerald. Mechanisms and sequelae of E‐cadherin silencing in hereditary diffuse gastric cancer. The Journal of Pathology 2008; 216(3): 295 doi: 10.1002/path.2426
|
3 |
Jacqueline Miranda de Lima, Lessileia Gomes de Souza, Ismael Dale Cotrim Guerreiro da Silva, Nora Manoukian Forones. E-Cadherin and Metalloproteinase-1 and -7 Polymorphisms in Colorectal Cancer. The International Journal of Biological Markers 2009; 24(2): 99 doi: 10.1177/172460080902400206
|
4 |
Abbas Moridnia, Mohammad Amin Tabatabaiefar, Mehrdad Zeinalian, Mohammad Minakari, Majid Kheirollahi, Noushin Afshar Moghaddam. Novel Variants and Copy Number Variation in CDH1 Gene in Iranian Patients with Sporadic Diffuse Gastric Cancer. Journal of Gastrointestinal Cancer 2019; 50(3): 420 doi: 10.1007/s12029-018-0082-7
|
5 |
Parry Guilford, Bostjan Humar. Spotlight on Familial and Hereditary Gastric Cancer. 2013; : 51 doi: 10.1007/978-94-007-6570-2_6
|
6 |
M. A. Cheong, K. S. Kim, G. S. Lee. The pharmacodynamics of mivacurium in the rabbit with carbon tetrachloride-induced liver disease. European Journal of Anaesthesiology 2007; 24(9): 789 doi: 10.1017/S0265021507000397
|
7 |
Ho H. Phan, Christine S. Cocanour. Necrotizing soft tissue infections in the intensive care unit. Critical Care Medicine 2010; 38: S460 doi: 10.1097/CCM.0b013e3181ec667f
|
8 |
XIAO-LING ZHANG, CHENG-XIN HUANG, JIE ZHANG, AKIRA INOUE, SI-EN ZENG, SHENG-JUN XIAO. CtBP1 is involved in epithelial-mesenchymal transition and is a potential therapeutic target for hepatocellular carcinoma. Oncology Reports 2013; 30(2): 809 doi: 10.3892/or.2013.2537
|
9 |
Ferdinando De Vita, Natale Di Martino, Alessio Fabozzi, Maria Maddalena Laterza, Jole Ventriglia, Beatrice Savastano, Angelica Petrillo, Valentina Gambardella, Vincenzo Sforza, Luigi Marano, Annamaria Auricchio, Gennaro Galizia, Fortunato Ciardiello, Michele Orditura. Clinical management of advanced gastric cancer: The role of new molecular drugs. World Journal of Gastroenterology 2014; 20(40): 14537-14558 doi: 10.3748/wjg.v20.i40.14537
|
10 |
HUI QU, RUICHUAN SHI, BOWEN YANG, XI CHEN, YUJIA SONG, LINGZI HE, YITING SUN, YUJING YANG, ZHI LI, XIUJUAN QU. HAND2-AS1, PRKAA2 and VLDLR predict the risk of peritoneal metastasis in gastric cancer of different Lauren types based on STEPP analysis. BIOCELL 2022; 46(3): 721 doi: 10.32604/biocell.2021.015867
|
11 |
Shamshul Ansari, Boldbaatar Gantuya, Vo Phuoc Tuan, Yoshio Yamaoka. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. International Journal of Molecular Sciences 2018; 19(8): 2424 doi: 10.3390/ijms19082424
|
12 |
Gaetano Piccolo, Antonio Zanghì, Maria Di Vita, Pietro Bisagni, Francesca Lecchi, Andrea Cavallaro, Francesco Cardì, Emanuele Lo Menzo, Alessandro Cappellani, Valli De Re. The role of E-cadherin expression in the treatment of western undifferentiated early gastric cancer: Can a biological factor predict lymph node metastasis?. PLOS ONE 2020; 15(4): e0232429 doi: 10.1371/journal.pone.0232429
|
13 |
Giovanni Corso, Joana Carvalho, Daniele Marrelli, Carla Vindigni, Beatriz Carvalho, Raquel Seruca, Franco Roviello, Carla Oliveira. Somatic Mutations and Deletions of the E-Cadherin Gene Predict Poor Survival of Patients With Gastric Cancer. Journal of Clinical Oncology 2013; 31(7): 868 doi: 10.1200/JCO.2012.44.4612
|
14 |
So Hyun Park, Jung Ran Choi, Ji Young Song, Kyu Keun Kang, Woong Sun Yoo, Sung Wan Han, Choon Kwan Kim. Necrotizing Fasciitis of the Thigh Secondary to Radiation Colitis in a Rectal Cancer Patient. Journal of the Korean Society of Coloproctology 2012; 28(6): 325 doi: 10.3393/jksc.2012.28.6.325
|
15 |
Satoshi Fujii, Atsushi Ochiai. Enhancer of zeste homolog 2 downregulates E‐cadherin by mediating histone H3 methylation in gastric cancer cells. Cancer Science 2008; 99(4): 738 doi: 10.1111/j.1349-7006.2008.00743.x
|
16 |
Lara Alessandrini, Melissa Manchi, Fabrizio Italia, Tiziana Perin, Vincenzo Canzonieri. Gastric Cancer In The Precision Medicine Era. Current Clinical Pathology 2019; : 155 doi: 10.1007/978-3-030-04861-7_10
|
17 |
Kentaro Sato, Hitoshi Yamamura, Yoshiyuki Sakamoto, Hajime Morohashi, Takuya Miura, Toru Yoshikawa, Akiko Suto, Satoru Tsuruta, Kenichi Hakamada. Necrotizing fasciitis of the thigh due to penetrated descending colon cancer: a case report. Surgical Case Reports 2018; 4(1) doi: 10.1186/s40792-018-0544-y
|
18 |
Andrea Rebeca Bustos-Carpinteyro, Carla Oliveira, Abel Sousa, Patricia Oliveira, Hugo Pinheiro, Joana Carvalho, María Teresa Magaña-Torres, María Guadalupe Flores-Miramontes, Adriana Aguilar-Lemarroy, Luis Felipe Jave-Suárez, Jorge Peregrina-Sandoval, José Alfonso Cruz-Ramos, Josefina Yoaly Sánchez-López. CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5294-0
|
19 |
Lara Alessandrini, Melissa Manchi, Valli De Re, Riccardo Dolcetti, Vincenzo Canzonieri. Proposed Molecular and miRNA Classification of Gastric Cancer. International Journal of Molecular Sciences 2018; 19(6): 1683 doi: 10.3390/ijms19061683
|
20 |
Patrícia Carneiro, Joana Figueiredo, Renata Bordeira-Carriço, Maria Sofia Fernandes, Joana Carvalho, Carla Oliveira, Raquel Seruca. Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. Expert Opinion on Therapeutic Targets 2013; 17(10): 1187 doi: 10.1517/14728222.2013.827174
|
21 |
JUNLI MA, HONG SHEN, LINDA KAPESA, SHAN ZENG. Lauren classification and individualized chemotherapy in gastric cancer. Oncology Letters 2016; 11(5): 2959 doi: 10.3892/ol.2016.4337
|
22 |
Joana Carvalho, Nicole C van Grieken, Patricia M Pereira, Sónia Sousa, Marianne Tijssen, Tineke E Buffart, Begoña Diosdado, Heike Grabsch, Manuel AS Santos, Gerrit Meijer, Raquel Seruca, Beatriz Carvalho, Carla Oliveira. Lack of microRNA‐101 causes E‐cadherin functional deregulation through EZH2 up‐regulation in intestinal gastric cancer. The Journal of Pathology 2012; 228(1): 31 doi: 10.1002/path.4032
|
23 |
Brinda Rao Korivi, Silvana Faria, Asran Aly, Jia Sun, Madhavi Patnana, Corey T. Jensen, Nicolaus Wagner-Bartak, Priya R. Bhosale. Intestinal and diffuse gastric cancer: a retrospective study comparing primary sites. Clinical Imaging 2019; 56: 33 doi: 10.1016/j.clinimag.2019.03.002
|
24 |
Miguel Cainzos, Francisco J Gonzalez-Rodriguez. Necrotizing soft tissue infections. Current Opinion in Critical Care 2007; 13(4): 433 doi: 10.1097/MCC.0b013e32825a6a1b
|
25 |
Maider Ibarrola-Villava, Marta J. Llorca-Cardeñosa, Noelia Tarazona, Cristina Mongort, Tania Fleitas, José Alejandro Perez-Fidalgo, Susana Roselló, Samuel Navarro, Gloria Ribas, Andrés Cervantes. Deregulation ofARID1A,CDH1,cMETandPIK3CAand target-related microRNA expression in gastric cancer. Oncotarget 2015; 6(29): 26935 doi: 10.18632/oncotarget.4775
|
26 |
Yong-Quan Chu, Zai-Yuan Ye, Hou-Quan Tao, Yuan-Yu Wang, Zhong-Sheng Zhao. Relationship between cell adhesion molecules expression and the biological behavior of gastric carcinoma. World Journal of Gastroenterology 2008; 14(13): 1990-1996 doi: 10.3748/wjg.14.1990
|